Natera, Inc. NTRA 390.79 -2.81% NMS · Healthcare
Open terminal

Natera, Inc. (ntra)

Unlock full data in Terminal →

NTRA Dividends

Dividend yieldNot applicable
Forward P/E-3751.82

The figure above is this ticker’s indicated or trailing dividend yield. Yield means annual dividend divided by the current share price. A 12-month (TTM) yield uses dividends already paid; the forward yield uses the expected next year. Dividend yield meaning — then confirm the live payout for Natera, Inc. (NTRA) in Vest Terminal.

Start Free — open NTRA in Vest Terminal

Access live data, filings, ownership, and analysis for Natera, Inc..

Create free account See plans

Natera, Inc. FAQ

What does Natera, Inc. (NTRA) do?

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients p…

What is NTRA's P/E ratio?

Natera, Inc. has a trailing P/E of N/A× based on publicly available market data.

Does NTRA pay a dividend?

Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.

What sector is NTRA in?

Natera, Inc. is classified in Healthcare (Diagnostics & Research) on NMS.

What is NTRA's market capitalization?

Approximate market cap: $56.33B.

What are the main risks for NTRA?

Key risks include above-average volatility (beta 1.53), among factors on this page.

What are the strengths of NTRA?

Potential positives include revenue growth of 37.7% year-over-year, gross margin of 65.2% supports competitive unit economics.

Where can I get analyst estimates for NTRA?

Public analyst price targets and consensus for Natera, Inc. are on the free /stocks/ntra/estimates page. Deeper estimate history and models are available in Vest Terminal.